Thier on the Institute of Medicine

Director of the Institute of Medicine since 1985, Samuel 0. Thier has succeeded in increasing both its budget and its public profile. In doing so, the Brooklyn native has been able to draw upon his experience as an academic physician and administrator. A Cornell University graduate, Thier received his MD degree from the State University of New York at Syracuse in 1960. He went to Massachusetts General Hospital in Boston as an intern and eventually became chief of its renal unit, while also jo

Written byTabitha M. Powledge
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

Director of the Institute of Medicine since 1985, Samuel 0. Thier has succeeded in increasing both its budget and its public profile. In doing so, the Brooklyn native has been able to draw upon his experience as an academic physician and administrator.

A Cornell University graduate, Thier received his MD degree from the State University of New York at Syracuse in 1960. He went to Massachusetts General Hospital in Boston as an intern and eventually became chief of its renal unit, while also joining the Harvard University Medical School faculty. In 1969 he moved to the University of Pennsylvania Medical School, where he also was associate director of medical services at the university hospital.

Thier moved to the Yale University School of Medicine in 1975 as chairman of the department of internal medicine. Three years later, he also was named chief of medicine at the Yale-New Haven Hospital. Thier, whose ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies